top of page

Ongoing Clinical Trials in
APOL-1 mediated Kidney Disease

BARICITINIB: JUSTICE TRIAL


Baricitinib inhibits Janus kinase (JAK) enzymes, which are intracellular enzymes involved in stimulating hematopoiesis...

INAXAPLIN


People with homozygosity or compound heterozygosity  for G1 and G2 risk alleles are at high risk of developing multiple kidney...

List of Updated Clinical Trials for APOL-1 mediated Kidney Disease

bottom of page